Literature DB >> 14207789

STROMAL CHANGES IN LEUKAEMIC AND RELATED BONE MARROW PROLIFERATIONS.

N G SANERKIN.   

Abstract

The stromal structure of the bone marrow was studied in 96 cases of leukaemia and related disorders. The reticulin stroma forms an integral component of any given marrow proliferation and may often be increased in amount, sometimes normal, and occasionally decreased. The pattern is often indeterminate but certain distinguishable patterns may be found, including a sinusoidal pattern in myelofibrotic chronic myeloses, a pattern characterized by an abundance of hyperplastic capillaries and arterioles often seen in lymphoid leukaemias, and one with irregular focal reticulin proliferation in many acute undifferentiated leukaemias.Adventitious collagen fibres are demonstrable in about half of all myeloses, acute and chronic, leukaemic and aleukaemic, and may be diffuse or focal. They apparently develop from thickening and collapse and condensation of the basic reticulin network, not from any primary fibroblastic proliferation. The development of fibrosis does not denote an aetiological relationship between the conditions in which it occurs, since it appears to be a non-specific sequel to marrow exhaustion and marrow necrosis. There is no justification for the diagnosis of acute or ;malignant' myelofibrosis as a disease entity in cases of acute leukaemia with marrow fibrosis.Osteolytic change due to resorption of bony trabeculae is a common event in all the conditions studied and may be accompanied by remoulding of the eroded trabeculae. Fibre bone formation is found in about 15% of cases, including acute lymphoblastic leukaemias and acute undifferentiated leukaemias, but is extensive and well-developed only in cases of primary myelofibrosis.

Entities:  

Keywords:  BONE MARROW CELLS; BONE MARROW DISEASES; CELL DIVISION; COLLAGEN; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MONOCYTIC; MYELOFIBROSIS; MYELOID METAPLASIA; PATHOLOGY

Mesh:

Substances:

Year:  1964        PMID: 14207789      PMCID: PMC480811          DOI: 10.1136/jcp.17.5.541

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  MALIGNANT MYELOSCLEROSIS.

Authors:  S M LEWIS; L SZUR
Journal:  Br Med J       Date:  1963-08-24

2.  The reticulin content of bone marrow in haematological disorders.

Authors:  J BURSTON; J L PINNIGER
Journal:  Br J Haematol       Date:  1963-04       Impact factor: 6.998

3.  Myelosclerosis; a clinico-pathological study.

Authors:  B J LEONARD; M C ISRAELS; J F WILKINSON
Journal:  Q J Med       Date:  1957-01

4.  Myelonecrosis, extramedullary myelopoiesis, and leuko-erythroblastosis: a mesenchymal reaction to injury.

Authors:  R J PEACE
Journal:  Am J Pathol       Date:  1953 Nov-Dec       Impact factor: 4.307

5.  Some speculations on the myeloproliferative syndromes.

Authors:  W DAMESHEK
Journal:  Blood       Date:  1951-04       Impact factor: 22.113

6.  The value of rib biopsy in the study of marrow disorders.

Authors:  M S R HUTT; P SMITH; A E CLARK; J L PINNIGER
Journal:  J Clin Pathol       Date:  1952-08       Impact factor: 3.411

7.  Myeloid metaplasia.

Authors:  M BLOCK; L O JACOBSON
Journal:  J Am Med Assoc       Date:  1950-08-19

8.  Chronic marrow failure, myelosclerosis and extramedullary hematopoiesis.

Authors:  J P WYATT; S C SOMMERS
Journal:  Blood       Date:  1950-04       Impact factor: 22.113

9.  Aleukemic Myelosis: Chronic Nonleukemic Myelosis, Agnogenic Myeloid Metaplasia, Osteosclerosis, Leuko-Erythroblastic Anemia, and Synonymous Designations.

Authors:  E L Heller; M G Lewisohn; W E Palin
Journal:  Am J Pathol       Date:  1947-05       Impact factor: 4.307

  9 in total
  6 in total

1.  Studies on the exchange of leukocytes between blood and bone marrow in chronic myelogenous leukemia.

Authors:  G Chikkappa; P R Galbraith
Journal:  Can Med Assoc J       Date:  1967-07-08       Impact factor: 8.262

2.  Thorotrast administration followed by myelofibrosis.

Authors:  A G Arnold; M H Oelbaum
Journal:  Postgrad Med J       Date:  1980-02       Impact factor: 2.401

3.  Studies on the longevity, sequestration and release of the leukocytes in chronic myelogenous leukemia.

Authors:  P R Galbraith
Journal:  Can Med Assoc J       Date:  1966-09-03       Impact factor: 8.262

4.  High expression of connective tissue growth factor accelerates dissemination of leukaemia.

Authors:  J E Wells; M Howlett; H M Halse; J Heng; J Ford; L C Cheung; A L Samuels; M Crook; A K Charles; C H Cole; U R Kees
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

5.  Bone marrow fibre content in acute myeloid leukaemia before and after treatment.

Authors:  A Islam; D Catovsky; J M Goldman; D A Galton
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

6.  Ultrastructure of blastic crisis in osteomyelofibrosis. A report of 2 cases with some unusual features.

Authors:  J Thiele; K F Vykoupil; A Georgii
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.